bioRxivMicrobiology
Heterologous Expression of NoxA Confers Aerotolerance in Clostridium sporogenes
Abstract
Clostridium is a genus of Gram-positive obligate anaerobic bacteria. Some species of Clostridium, including C. sporogenes, may be of use in bacteria-mediated cancer therapy. Spores of Clostridium are inert in healthy normoxic tissue, but germinate when in the hypoxic regions of solid tumors, causing tumor regression. However, such treatments fail to completely eradicate tumors because of higher oxygen levels rise at the tumors outer rim. In this study, we demonstrate that a degree of aerotolerance can be introduced to C. sporogenes by transfer of the noxA gene from C. aminovalericum. NoxA is a water-forming NADH oxidase enzyme. Thus, its activity has no detrimental effect on cell viability. In addition to its potential in cancer treatment, the noxA-expressing strain described here could be used to alleviate challenges related to oxygen sensitivity of C. sporogenes in biomanufacturing.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Impact of fungal hyphae on growth and dispersal of obligate anaerobic bacteria in aerated habitats
B. Xiong, S. Kleinsteuber, … L. Y. Wick·bioRxiv·Mar 3, 2022
- A superoxide reductase contributes to Clostridioides difficile resistance to oxygen
R. Kochanowsky, K. E. Carothers, … G. Vedantam·bioRxiv·Dec 19, 2022
- An orphan cbb3-type cytochrome oxidase subunit supports Pseudomonas aeruginosa biofilm growth and virulence
J. Jo, K. L. Cortez, … L. E. P. Dietrich·bioRxiv·Aug 2, 2017
- Rational engineering of facultative anaerobiosis enables commensal survival in the oxygenated gut
Abigail E. Rose, Madison Langford-Butler, … Wenhan Zhu·bioRxiv·Jun 6, 2026
- Clarifying Microbial Nitrous Oxide Reduction Under Aerobic Conditions: Tolerant, Intolerant, and Sensitive
S. Ishii, Z. Wang, … S. Kowaliczko·bioRxiv·Oct 27, 2022
- NADH as a cancer medicine
Michael D. Forrest·bioRxiv·May 13, 2015